Organigram to Announce Q4 2025 Earnings on December 16
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from OrganiGram Holdings ( (TSE:OGI) ) is now available.
Organigram Global Inc. announced on December 5, 2025, that it will release its fourth quarter fiscal 2025 earnings results on December 16, 2025. The company will host a conference call to discuss the results, which could impact its market positioning and stakeholder interests, given its status as Canada’s top cannabis company by market share.
The most recent analyst rating on (TSE:OGI) stock is a Hold with a C$2.50 price target. To see the full list of analyst forecasts on OrganiGram Holdings stock, see the TSE:OGI Stock Forecast page.
Spark’s Take on TSE:OGI Stock
According to Spark, TipRanks’ AI Analyst, TSE:OGI is a Neutral.
OrganiGram Holdings’ overall score reflects strong earnings performance and market position, offset by technical weakness and valuation concerns. The company’s financial performance shows potential, but cash flow management needs improvement. The positive sentiment from the earnings call suggests a promising long-term trajectory, despite current challenges.
To see Spark’s full report on TSE:OGI stock, click here.
More about OrganiGram Holdings
Organigram Global Inc. is a leading cannabis company in Canada, listed on NASDAQ and TSX. It focuses on producing high-quality cannabis for adult recreational use and expanding its global footprint through international partnerships. The company has a diverse portfolio of cannabis brands and operates multiple facilities in Canada, including those optimized for edibles manufacturing and cannabinoid processing.
Average Trading Volume: 186,353
Technical Sentiment Signal: Buy
Current Market Cap: C$307.6M
For a thorough assessment of OGI stock, go to TipRanks’ Stock Analysis page.
